In a consensus decision aimed at protecting the world from future infectious diseases crises, the World Health Assembly on 1 December 2021 agreed to kickstart a global process to draft and negotiate a convention under the Constitution of the World Health Organization to strengthen pandemic prevention, preparedness and response.
WHO’s COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) have finalized a licensing agreement with the Spanish National Research Council (CSIC) for a COVID-19 serological antibody technology. The test effectively checks for the presence of anti-SARS-CoV-2 antibodies developed either in response to a COVID-19 infection or to a vaccine. This represents the […]
Thrombolytic Science (TSI) has been granted a new patent by the USPTO for an invention that relates to methods for a safe and effective clot dissolution that mimics the natural biological system. Most strokes and all heart attacks are caused by a blood clot blocking essential blood flow to a portion of the brain or […]
The U.S. FDA has approved Takeda Pharmaceuticals’ Livtencity (maribavir) as the first drug for treating adults and paediatric patients (12 years of age and older and weighing at least 35 kilograms) with post-transplant cytomegalovirus (CMV) infection that does not respond to available antiviral treatment for CMV. Livtencity works by preventing the activity of human cytomegalovirus […]
The United Kingdom’s Cambridgeshire and Peterborough’s integrated care system has signed an eight-year contract with Orion Health to develop a shared care record that will be used by eight health and care organisations and all the GP practices in its area.
The United States Centers for Disease Control and Prevention (CDC) will invest $26 million in funding to develop next-generation infectious disease forecasting and analytics. The agency will provide $21 million to support research and development of advanced infectious disease models and analytical tools. The awards will support three years of work at five leading academic […]
Hologic, a global leader in women’s health, has completed its acquisition of Bolder Surgical, a privately held, U.S.-based company that provides advanced energy vessel sealing surgical devices.
The 44th World Hospital Congress (WHC) came to an upbeat close on 11 November in Barcelona, Spain, a year later than originally planned due to the Covid-19 pandemic.
There was an abundance of news emanating from this year’s RSNA in Chicago with exhibitors launching new products, showcasing developments to their product portfolios and highlighting advances they have made with the use of artificial intelligence. Here is a brief selection of some of the news coming out of this major event for the healthcare […]
The SuperSonic MACH 40 system uses Hologic’s “UltraFast” imaging technology – inspired by cutting-edge graphics innovations from the video gaming industry – to provide greater frame rates of up to 20,000 images per second. The technology also enables innovative imaging modes, without the trade-offs present in conventional systems. Hologic says this forward-thinking, powerful architecture primes […]
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.